Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 28;331(20):1709-1711.
doi: 10.1001/jama.2024.4828.

The Aspirin Conundrum-Navigating Negative Results, Age, Aging Dynamics, and Equity

Jeanne S Mandelblatt  1   2 , Candace Mainor  3 , Barry I Hudson  4
Affiliations
Editorial

The Aspirin Conundrum-Navigating Negative Results, Age, Aging Dynamics, and Equity

Jeanne S Mandelblatt et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Mandelblatt reported having a pending patent for application (PCT/US2022/028741) filed by Georgetown University titled “Use of RAGE Inhibitors to Treat Cancer-Related Cognitive Decline” and licensed to Cantex Pharmaceuticals (she waived her rights and will not receive any remuneration, consideration, or revenue generated from this license or the patents and patent applications licensed thereunder); and reported being a member of the Alliance Cancer in the Older Adult Committee. Dr Mainor reported receiving the study drug from Cantex Pharmaceuticals and institutional support from Pfizer for a clinical trial outside the submitted work. Dr Hudson is a coinventor on a pending invention patent application (PCT/US2022/028741) filed by Georgetown University titled “Use of RAGE Inhibitors to Treat Cancer-Related Cognitive Decline” and licensed to Cantex Pharmaceuticals; and is a coinventor on a pending Canadian patent application (CA3118711A1) filed by the University of Miami titled “Method for Treating Breast Cancer and Chronic Diseases,” whose development was supported by the Florida Department of Health, Bankhead-Coley Cancer Biomedical Research Program grant 8BC06. No other disclosures were reported.

Comment on

References

    1. Chen WY, Ballman KV, Partridge AH, et al. Aspirin vs placebo as adjuvant therapy for breast cancer: the Alliance A011502 randomized trial. JAMA. Published online April 29, 2024. doi:10.1001/jama.2024.4840 - DOI - PMC - PubMed
    1. Chen WY, Holmes MD. Role of aspirin in breast cancer survival. Curr Oncol Rep. 2017;19(7):48. doi: 10.1007/s11912-017-0605-6 - DOI - PubMed
    1. Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379(9826):1591–1601. doi:10.1016/S0140-6736(12)60209-8 - DOI - PubMed
    1. Tan MP, Silva E. Addressing the paradox of increasing mastectomy rates in an era of de-escalation of therapy: communication strategies. Breast. 2018;38:136–143. doi:10.1016/j.breast.2017.12.010 - DOI - PubMed
    1. Norton WE, Chambers DA. Unpacking the complexities of de-implementing inappropriate health interventions. Implement Sci. 2020;15(1):2. doi:10.1186/s13012-019-0960-9 - DOI - PMC - PubMed

Substances